NCT04477239View on ClinicalTrials.gov

Diagnostic Performance of Urinary Gluten Immunogenic Peptides in Monitoring the Adherence to Gluten-free Diet.

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

December 31, 2020

Conditions
Celiac Disease
Interventions
BEHAVIORAL

Gluten (behaviour)

Gluten is a protein normally present in the daily diet of healthy volunteers not suffering from gluten related disorders, in far greater quantities (10-20 g/day) than those used in this study (10 mg-1 g/day).

BEHAVIORAL

Placebo (behaviour)

Placebo is composed of pregelatinized maize starch Ph.Eur. 97.5%; magnesium stearate Ph.Eur. 1.5%; micronized silica Ph.Eur. 0.5%; Micronized talc Ph.Eur. 0.5% (NOT containing preservatives, colorings, or gluten).

Trial Locations (1)

60123

University Department of Pediatrics, Ancona

All Listed Sponsors
lead

Università Politecnica delle Marche

OTHER

NCT04477239 - Diagnostic Performance of Urinary Gluten Immunogenic Peptides in Monitoring the Adherence to Gluten-free Diet. | Biotech Hunter | Biotech Hunter